The PennZone

  • Home
  • Non-profit
  • Technology
  • Education
  • Business
  • Construction
  • Entertainment
  • Event
  • Marketing

Dr. Jeff Gelblum Opens Jupiter Neurology Office with Infusion Center
The PennZone/10287893

Trending...
  • Creative Investment Research Analysis Finds Slower GDP Growth, Rising Inflation
  • Tru by Hilton El Paso Airport Opens to Guests
  • Zenylitics Announces Leadership Transition to Continue Accelerated Growth
Jupiter Neurology and Infusion Center
Dementia Specialist, Dr. Jeffrey Gelblum, Expands the Infusion Center in his Jupiter Neurology Office.

JUPITER, Fla. - PennZone -- To accommodate the exploding need for neurology services in Palm Beach, Martin, and St. Lucie counties, Jupiter Neurologist,  Dr. Jeff Gelblum, proudly announces the expansion of his in-office infusion center located at 601 University Boulevard, Suite 102, in Jupiter, Florida.

Dr. Gelblum observes that an explosion of newly approved IV therapies for the treatment of Alzheimer's, MS, myasthenia gravis, and migraine warrant his center's increased capacity for IV treatment.

"Our Jupiter Infusion Center had been running at full capacity, and with the approval of even more disease-modifying treatments for severe neurologic conditions, we are now poised to meet the growing needs of our tri-county clientele," states Dr. Gelblum.

The infusion center accepts most insurances and eagerly welcomes referrals from all physicians and specialists in the community, including rheumatologists and other neurologists.

More on The PennZone
  • Top 15 Mosquito-Infested Cities in Louisiana and East Texas Ranked for 2026 Mosquito Season
  • Colonial Nissan Enhances Ownership Experience with Hall of Fame Package
  • From Broken to Soaring Week 40
  • Costa Oil Takes the Spotlight as Primary Sponsor at Pocono, Celebrates Team with Employee Appreciation Day Costa Oil to back the
  • MoMojo Records announces new album from Mitch Woods

He concludes, "Our state-of-the-art neurology practice provides this area with top-notch clinical, diagnostic, and infusion care. As our community grows, we are dedicated to fulfilling the growing expectations of our patients and colleagues."

About Jeffrey Gelblum, MD, FAAN

Dr. Jeffrey Gelblum is a board-certified neurologist with offices in Aventura and Jupiter, Florida. He has successfully treated thousands of patients over 25 years, from South Florida and worldwide. He is considered a global thought leader in the neurologic treatment of dementia, seizure disorders, Parkinson's, Diabetic and Peripheral Nerve Disorder, Covid Long-Hauler, trauma, chronic pain, and more. He has hosted educational symposia in the U.S. and overseas.

Dr. Gelblum maintains numerous research FDA-sponsored affiliations, providing patients immediate access to promising new treatment protocols. He is active in multiple community outreach programs to educate the public regarding the care and treatment of neurologic disorders.

Learn more about Dr. Gelblum at https://www.fcneurology.net/business-directory/788/jeffrey-gelblum-md/

Contact
First Choice Neurology
***@jmurrayassoc.com


Source: First Choice Neurology

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • netElastic Powers LigaT's High-Performance Broadband Expansion and IPv6 Modernization in Portugal
  • IWS Press Expands Best-Selling Classic Wealth Library with Seventh Book
  • Raiku launches rkuSOL with Sanctum, Kamino, Loopscale and Exponent
  • Greenland Mines Ltd (N A S D A Q: GRML) Advances Strategic Growth Initiatives as Critical Minerals Demand Accelerates
  • Entering the $69 Billion Animal Health Market, Delivering Record Growth, AI-Driven Healthcare Innovation, and Targeting $200 Million Revenue by 2029
  • $97.9 Million Q1 Revenue Growth Reinforces Transformation Into a Global AI & Digital Services Powerhouse: IQSTEL, Inc. (N A S D A Q: IQST)
  • Philadelphia Scientist Roohid Parast Applies Evidence-Based Research to Elite Personal Fitness
  • Boston Industrial Solutions Launches NatronĀ® 348 UV Inkjet Ink for Epson S3200 Print Heads
  • Heritage at South Brunswick Unveils Luxury Resort-Style Amenities Designed for Every Generation
  • CAPHRA warns push for ASEAN vape ban ignores science
  • Your Mortgage Toolbox Launches Free Mortgage Calculators That Show the Real Monthly Payment and Cash Needed to Close
  • ENTOUCH Recognized on Inc.'s 2026 Best Workplaces List for the Third Year Running
  • P-Wave Classics Opens Pre-Orders for Volume II of Robert Bage's Hermsprong
  • Cabinetworks Group announces recipient of 2025 Plant of the Year
  • Honesdale Painters Launch Season With Act of Community Kindness
  • Tuckwell Machinery Launches New Range of Woodworking Machinery
  • A Brave Little Hero with Four Paws
  • Pittsburgh-Area Author Erica L. Day Releases HER, a Christian Second-Chance Romance and Its Own Comp
  • Revenue Optics Expands Its Private Equity Practice as Sponsors Move Inside Sales to the Center of Distribution Value Creation
  • Ecuador Freedom Launches First Scheduled Motorcycle Tour of Northern Peru's Lost Kingdoms

Popular on PennZone

  • People & Stories/Gente y Cuentos Welcomes Two New Trustees as Organization Enters 54th Year and Expands Community Reach
  • Resident Inspect Joins Property Meld Nexus Network with API Integration
  • Assymetrix Launches the Deepest Independent Prediction Market Data API
  • RAS AP Consulting Advances to RFP Stage in Heidelberg Materials' SAP Vendor & Customer Master Data Modernization Initiative
  • New Home of the Month: Spacious Luxury Meets Modern Design in The Bristol at Heritage at Manalapan
  • Expert E-Bike Safety Advocate Issues Urgent Warning Following Recent Southern California Fatalities
  • CCHR: 'Plant-Based' Psychedelics Push Masks Synthetic Drugs and Billion-Dollar Profits
  • Umbrella Becomes First FinOps Platform to Support AWS Billing Transfer Onboarding
  • Veikkaus Appoints New CFO as Finland's Gambling Monopoly Braces for Breakup
  • ICTPBX Released: White-Label, Multi-Tenant Open Source PBX Platform for ITSPs

Similar on PennZone

  • Entering the $69 Billion Animal Health Market, Delivering Record Growth, AI-Driven Healthcare Innovation, and Targeting $200 Million Revenue by 2029
  • CAPHRA warns push for ASEAN vape ban ignores science
  • Lineus Medical Completes Financial Restructuring with KMF Investments- Launching a New Era for SafeBreak
  • Neuro Recovery Institute Showcases Emerging Immersive Neuro-Rehabilitation Technology at Clinical Innovation Open House
  • Industrial and systems engineers celebrate key leaders in the field at IISE Annual Conference
  • CCHR Leader's 50-Year Fight for Psychiatric Drug Victims Gains National Momentum
  • Author Releases 7-Day Screen Time Reset for Families as Teachers Worldwide Report Children "Struggling to Grasp Basic Concepts"
  • Men's Health Month Begins with Record Proclamations, AP News Coverage, & National Momentum for Men's Health
  • Blueshirt Media Launches HIPAA-Compliant AI Call Answering for Addiction Treatment Centers
  • Wellness Technology Distributor Helping People Set Up Wellness Center Businesses
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us